Insider Buys
This tool is in beta, validation in progress.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Risk Factors Update Summary
- Our recent acquisition of Immunetrics may involve up to $8.0 million in earnout payments, contingent on financial goals.
- Increased competition could lead to price concessions, adversely affecting our operating results and profitability.
- We face potential liabilities in contract research services, including errors in reporting study details, which could impact our operations significantly.
- Our reliance on a single internal hosting facility and Amazon Web Services poses risks to data protection and operational integrity.
- Changes in data privacy laws, including the EU GDPR and UK GDPR, could materially affect our reputation and operations.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1023459&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.